Every 10-Q that AMPLITECH GROUP INC. COM (AMPG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow AMPG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMPG filings page.
AmpliTech Group, Inc. reported Q2 2026 revenue of $8.1 million, down 26.81% from Q2 2025, and six‑month 2026 revenue of $13.4 million, down 8.24%. Despite lower sales, gross profit improved to $2.3 million in Q2 and $4.8 million for six months, with gross margin rising to 27.93% in Q2 and 35.92% year‑to‑date, driven by a more favorable product mix and the absence of lower‑margin acquired 5G product sales.
Operating expenses rose sharply as the company invested in 5G development, marketing, trade shows, consulting and stock‑based compensation, lifting SG&A to $7.8 million and R&D to $1.9 million for the first half. As a result, the net loss widened to $3.1 million in Q2 and $4.6 million for six months, and operating activities used $8.7 million of cash.
Liquidity strengthened through a rights offering and a registered direct offering that together added over $16.4 million of equity capital in the first half, ending June 30 with $8.9 million in cash and cash equivalents, $22.9 million of working capital, and $46.8 million of stockholders’ equity. Subsequent to quarter‑end, the company raised approximately $21.9 million from the exercise of Series A Rights and announced a $10 million stock repurchase program. Management continues to report material weaknesses in internal control over financial reporting and is pursuing its remediation plan.
AmpliTech Group, Inc. reported strong top-line growth but continued losses for the quarter ended March 31, 2026. Revenue rose to $5,349,446 from $3,599,099, driven largely by higher demand for 5G products, lifting gross margin to 47.98% from 33.00%.
The company posted a net loss of $1,521,707, narrower than the $1,840,521 loss a year earlier, as research and development spending declined while selling, general and administrative costs increased due to higher corporate expenses and stock-based compensation. Basic and diluted loss per share improved to $0.06 from $0.09.
Liquidity strengthened significantly through a rights offering and a registered direct offering, which together generated net proceeds of about $16.4M and increased stockholders’ equity to $48,360,710. Cash and cash equivalents were $11,807,881 and marketable securities $6,618,092, supporting working capital of $25,381,638. Management believes existing resources can fund operations for at least 12 months, but internal control over financial reporting and disclosure controls remained not effective due to ongoing material weaknesses.
AmpliTech Group (AMPG) reported stronger Q3 results with revenue of $6,093,832, more than doubling from the prior year quarter, and a narrower net loss of $188,373 (basic and diluted loss per share $0.01). Gross profit improved as higher volumes flowed through, though operating expenses rose with continued R&D and growth investments.
For the nine months, revenue reached $20,718,858 versus $7,655,285 a year ago, and net loss was $3,800,519 versus $7,421,118. Cash and cash equivalents were $8,387,194 at September 30, 2025, down from $19,315,984 at year-end, reflecting $5.26M used in operations and $5.67M used in investing, including the Titan 5G ORAN asset purchase. Intangible assets rose to $13,565,038 and a contingent liability of $3,000,000 was recorded tied to milestone payments. The distribution segment generated positive income while manufacturing and corporate costs weighed on results. One customer accounted for 48.33% of revenue for the nine months. Shares outstanding were 20,626,595 at quarter end; 20,638,095 as of November 11, 2025.